Robert W. Duggan - 16 Aug 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Executive Officer, Director
Signature
/s/ Robert W. Duggan
Issuer symbol
SMMT
Transactions as of
16 Aug 2022
Net transactions value
+$92,003,727
Form type
4
Filing time
18 Aug 2022, 16:38:34 UTC
Previous filing
10 Jun 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $92,003,727 +94,849,203 +140% $0.9700 162,532,792 16 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.